![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07J 43/00 | (2006.01) |
C07J 43/003 | (2013.01) | ||
A61K 31/58 | (2006.01) | ||
A61P 5/28 | (2006.01) | ||
A61P 5/46 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Patento numeris | 3935068 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 20717363.4 |
Europos patento paraiškos padavimo data | 2020-03-04 | |
(97) | Europos patento paraiškos paskelbimo data | 2022-01-12 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2023-09-06 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2020/020915 |
Data | 2020-03-04 |
(87) | Numeris | WO 2020/180942 |
Data | 2020-09-10 |
(30) | Numeris | Data | Šalis |
201962814568 P | 2019-03-06 | US | |
201962849259 P | 2019-05-17 | US |
(72) |
SHARP, Matthew, J. , US
MOORE, William, R. , US
|
(73) |
Propella Therapeutics, Inc. ,
480 Hillsboro Street Suite 130A, Pittsboro NC 27312,
US
|
(54) | ABIRATERONE PRODRUGS |
ABIRATERONE PRODRUGS |